The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...
Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...
ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Compliance Group (CG), a ...
Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...
A D.C. drugmaker is fighting the FDA on multiple fronts, from trying protect its intellectual property from generic ...
3d
Japan’s market growth accelerates through dynamic clinical partnerships, biologic breakthroughs, and automated facilities. Japanese firms confront shifting priorities in specialized therapies, ...
The US FDA has warned Sanofi about deviations from cGMP for active pharmaceutical ingredients at their Genzyme manufacturing plant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback